ADGM · XBRL financial data

Adagio Medical Holdings financial statements, every quarter

The same tables from 9 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (ADGM's year ends in late December)

In thousands of dollars	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	254	—	137*	0	0	0	0*	0	0
Cost of revenue	682	—	1,523*	253	342	31	58*	—	—
Research and development	2,865	—	3,417*	3,659	1,971	2,774	2,235*	2,741	2,450
Selling, general and administrative	3,366	—	4,050*	3,485	2,404	2,916	1,675*	2,459	2,484
Operating income (loss)	(6,659)	—	(58,055)*	(7,397)	(4,717)	(5,721)	(3,968)*	(5,200)	(4,934)
Interest income	2	—	254*	164	102	79	132*	107	72
Interest expense	760	—	670*	662	720	749	775*	778	805
Other income (expense)	5	—	1,825*	(46)	102	12	40*	70	(69)
Income tax expense (benefit)	—	—	year only	—	—	—	year only	—	—
Net income (loss)	(714)	—	(57,369)*	(7,713)	(3,947)	(10,118)	(3,306)*	(6,995)	(6,717)
Earnings per share, basic USD per share	(713,794.00)	(8.34)	—	(0.50)	(0.26)	(0.66)	(0.16)*	(0.31)	(0.30)
Earnings per share, diluted USD per share	(713,794.00)	—	—	(0.51)	(0.35)	(0.66)	—	(0.31)	(0.30)
Weighted average shares, basic thousands of shares	0	988	—	15,376	15,382	15,382	20,131*	22,210	22,210
Weighted average shares, diluted thousands of shares	0	—	—	15,376	15,382	15,382	20,131*	22,210	22,210

Fiscal quarters (ADGM's year ends in late December)

In thousands of dollars	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	0	28,260	20,586	12,963	8,200	4,673	17,105	12,909	7,740
Accounts receivable	—	90	35	1	—	—	—	—	—
Inventory	—	4,139	2,566	2,310	1,841	1,548	1,672	1,604	1,986
Total current assets	—	35,030	25,349	17,373	12,227	8,143	20,082	15,855	10,689
Property and equipment, net	—	1,572	1,961	2,093	1,882	1,701	1,535	1,325	1,127
Right-of-use asset	—	226	188	925	822	760	697	1,191	1,132
Goodwill	—	44,291	13,967	13,967	13,967	13,967	13,967	13,967	13,967
Total assets	—	107,196	48,448	41,338	35,876	31,546	43,253	39,308	33,884
Accounts payable	—	4,419	2,840	2,647	1,315	1,024	1,082	1,217	699
Accrued liabilities	—	2,910	3,673	3,096	3,364	8,498	6,996	7,131	6,634
Total current liabilities	—	7,919	7,763	6,006	4,884	9,702	8,233	8,573	7,562
Lease liability, non-current	—	85	46	668	629	596	563	992	936
Total liabilities	5	30,635	28,536	28,939	27,210	32,858	30,851	33,583	34,299
Accumulated deficit	(2,139)	(13,217)	(70,586)	(78,256)	(82,184)	(92,303)	(95,609)	(102,631)	(109,403)
Total stockholders' equity	(5)	76,561	19,912	12,399	8,666	(1,312)	12,402	5,725	(415)
Total liabilities and equity	—	107,196	48,448	41,338	35,876	31,546	43,253	39,308	33,884
Common shares outstanding (cover page) thousands of shares	13,388	14,535	15,382	15,382	15,382	21,180	22,210	22,210	22,210

Fiscal quarters (ADGM's year ends in late December)

In thousands of dollars	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(714)	—	(57,369)*	(7,713)	(3,947)	(10,118)	(3,306)*	(6,995)	(6,717)
Stock-based compensation	111*	—	—	218	234*	137*	890*	389	479*
Depreciation and amortization	257*	—	424*	271	271*	191*	237*	210	201*
Net cash from operating activities	6,739*	—	(7,111)*	(7,211)	(4,656)*	(3,009)*	(4,138)*	(4,126)	(5,260)*
Purchases of property and equipment	175*	—	702*	335	10*	520*	(491)*	2	6*
Net cash from investing activities	(175)*	—	(702)*	(335)	(10)*	(520)*	491*	(2)	(6)*
Proceeds from issuing common stock	—	—	—	—	—	—	year only	—	—
Net cash from financing activities	5,072*	—	—	—	—	—	year only	—	—
Net change in cash	(2,700)*	—	(7,674)*	(7,623)	(4,763)*	(3,527)*	12,432*	(4,196)	(5,169)*

SIC 3841 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (3841) companies nearest in public float, each marked “added: same SIC”.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Adagio Medical Holdings	7,740	0	(5,260)*	22.2M	1.5 quarters	Q2 FY26 10-QJun 30, 2026
Dynatronicsadded: same SIC	762	7,024	(93)	16.0M	8.2 quarters	Q1 FY26 10-QSep 30, 2025
Profusaadded: same SIC	719	not reported	(2,632)*	605,647	0.3 quarters	Q2 FY26 10-QJun 30, 2026
Premier Air Charter Holdingsadded: same SIC	157	5,784	318*	280.8M	—	Q2 FY26 10-QJun 30, 2026
QHSLabadded: same SIC	317	847	(7.8)*	15.0M	40.6 quarters	Q2 FY26 10-QJun 30, 2026
Vycor Medicaladded: same SIC	159	418	(4.8)*	33.4M	32.8 quarters	Q2 FY26 10-QJun 30, 2026
INVO Fertilityadded: same SIC	3,733	2,175	(1,101)*	2.5M	3.4 quarters	Q2 FY26 10-QJun 30, 2026
Stimcell Energeticsadded: same SIC	6.9	not reported	(109)	21.1M	0.1 quarters	Q1 FY27 10-QAug 31, 2026
Bluejay Diagnosticsadded: same SIC	9,599	not reported	(1,499)*	4.5M	6.4 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.